3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Other
1
Conditions
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
16
Leukemia
11
Precursor Cell Lymphoblastic Leukemia-Lymphoma
10
Lymphoma
8
Sezary Syndrome
4
Mycosis Fungoides
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Waldenstrom Macroglobulinemia
3
Lymphoma, T-Cell, Cutaneous
3
Lymphoma, Follicular
3
Lymphoma, B-Cell, Marginal Zone
3
Recurrence
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large-Cell, Anaplastic
2
Leukemia, Large Granular Lymphocytic
2
Leukemia, Biphenotypic, Acute
2
Immunoblastic Lymphadenopathy
2
Burkitt Lymphoma
2
Thrombocythemia, Essential
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Neoplasms, Plasma Cell
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Mucositis
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Interventions
Radiotherapy
9
Cisplatin
8
Fibroblast Growth Factor 7
6
Low-Level Light Therapy
5
angiotensin I (1-7)
4
Radiation
4
Injections
4
Propolis
3
Morphine
3
Methotrexate
3
Leucovorin
3
Drug Therapy
3
Cryotherapy
3
glucarpidase
2
aluminum hydroxide, magnesium hydroxide, drug combination
2
Xylitol
2
Water
2
Radiotherapy, Intensity-Modulated
2
RRx-001
2
Probiotics
2
Pentoxifylline
2
Mouthwashes
2
Melphalan
2
Lidocaine
2
Ketamine
2
Interleukin 1 Receptor Antagonist Protein
2
Honey
2
Glutamine
2
Gabapentin
2
Fluorouracil
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Mucositis
×
nelarabine
×
Clear all
NCT01085617
2025-03-30
UKALL14
University College, London
Completed